Idiopathic Pulmonary Fibrosis

Medical Condition: Pulmonary Fibrosis 

Facility/Clinic: COVID-19 

Age: 40 – 85

Gender: Male/Female


A research study is evaluating an investigational medication combined with standard-of-care treatment on lung function for adults diagnosed with idiopathic pulmonary fibrosis.

Qualified participants will receive all study-related care and study medication or placebo at no cost.

Enrollment: Open

Patient Commitment Duration: Approximately 1 year

Patient Compensation: Financial compensation may be provided for travel expenses. 

Number of visits in study: Approximately 18 clinic visits



Apply for this study below:

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.